Nichole Cruz

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 491 citations · Full text

Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · JAMA Oncology · 2021 · 108 citations · Full text

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia

Lisa S. Chen, Prithviraj Bose, Nichole Cruz et al. · Blood · 2018 · 100 citations · Full text

Combined Venetoclax and Ibrutinib for Patients with Previously Untreated High-Risk CLL, and Relapsed/Refractory CLL: A Phase II Trial

Nitin Jain, Philip A. Thompson, Alessandra Ferrajoli et al. · Blood · 2017 · 32 citations

Combined Ibrutinib and Venetoclax in Patients with Treatment-Naïve High-Risk Chronic Lymphocytic Leukemia (CLL)

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · Blood · 2018 · 18 citations